Sr Director Quantitative Pharmacology
EMD Serono
Dr. Yulia Vugmeyster, PhD, is currently a Sr Director of Quantitative Pharmacology at EMD Serono, the healthcare business of Merck KGaA, with the focus on oncology and immune-oncology. She earned her PhD from the Massachusetts Institute of Technology. She has 20‐year pharmaceutical/biotech industry experience, advancing biologics and small molecule drugs from preclinical to clinical phases and to NDA/BLA approvals in multiple therapeutic areas. She has published both original research and review papers and has presented her research at multiple meetings.